NCT00321178View on ClinicalTrials.gov

BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

February 28, 2009

Conditions
Buruli UlcerMycobacterium Ulcerans
Interventions
DRUG

SR4 - switch to CR4

switch to oral treatment after 4 weeks SR 'standard' therapy

Trial Locations (2)

Unknown

Agogo Hospital, Agogo

Nkawie-Toaso Hospital, Nkawie

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT00321178 - BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA | Biotech Hunter | Biotech Hunter